Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China

Pfizer Inc. PFE and Zhejiang Hisun Pharmaceuticals today jointly announced the signing of a memorandum of understanding on their intention to establish a joint venture. This potential partnership would aim to strengthen the ability of both companies to reach more patients with high-quality and low-cost medicines in the branded generics arena.